Interview with James Kaw, Director, P&G Singapore Innovation Center (SgIC)
28.11.2012
Related Interviews
Stewart Campbell – VP & GM APAC, West
Stewart Campbell, Vice President and General Manager, Asia Pacific, West Pharmaceutical Services, highlights how the drug containment and delivery system industry is evolving to meet the rapidly changing needs of…
Angeline Ho – Communication & Patient Advocacy Lead, Oncology Cell…
Angeline Ho gives an overview of the patient advocacy landscape in Asia-Pacific, why an Asian model of patient engagement – distinct from those in Europe and the US – needs…
Cardiovascular Disease / Novartis APMA President on Sustainable Partnerships & Unblocking Access Barriers
On World Heart Day 2022 Iris Zemzoum of Novartis Asia Pacific, Middle East & Africa (APMA) outlines the devastating impact of cardiovascular disease (CVD) as well as Novartis’ multipronged approach…
Opinion / How Can the Generics Industry Up its Game on Essential Medicine Access?
Claudia Martínez, generic & biosimilar medicines programme manager at the Access to Medicine Foundation, draws from a recent AMF report to outline what more generics companies can be doing to…
Leadership / Bill Sibold Swaps Sanofi for Biotech Seeking First NASH FDA Approval
After a 12-year stint at Sanofi, Bill Sibold is leaving Big Pharma to join the Pennsylvania-based biotech Madrigal Pharmaceuticals as CEO. Sibold, no stranger to ground-breaking launches, having brought the…
MEA / Clinical Research in the UAE: Quickfire Progress & The Road Left to Travel
With cutting-edge hospital infrastructure being put in place, government authorities rolling out evermore supportive regulatory upgrades, big pharma championing ‘clinical trial diversity’ with greater non-Caucasian representation in trial cohorts, and…
